EFTRW Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 июнь 2024 @ 21:35):
Our systems believe the stock currently is undervalued by 0.94% compare to its pairs and should correct upwards.

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...

Stats
Объем за сегодня	108 152
Средний объем	0
Рыночная капитализация	641 019
EPS	$-2.16 ( Q1 \| 2024-05-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -6.49%

ABCL 2.02%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 4.43%

ABSI 4.76%

ABUS -0.66%

ABVX -1.21%

ACAD 0.00%

ACER -17.95%

ACET -8.50%

ACGN 1.29%

ACHL -2.48%

ACHV 3.88%

ACIU -1.00%

ACLX 0.42%

ACRV -5.61%

ACST -4.89%

ACXP 3.92%

ADAG 6.07%

ADAP -2.86%

ADGI 0.87%

ADIL -1.70%

ADMA -1.73%

ADPT 0.74%

ADTX -2.78%

ADVM 1.30%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.24%

AGIO -2.01%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.85%

AKRO -2.55%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC 0.00%

ALGS 1.32%

ALKS 1.86%

ALLK -11.44%

ALLO -3.97%

ALLR -2.55%

ALNA 3.16%

ALNY 1.84%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -14.15%

ALVR -0.69%

ALXN 0.00%

ALXO -13.55%

ALZN 4.02%

AMRN -2.51%

AMTI -3.13%

ANAB 1.25%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.96%

ANPC -3.15%

APGE 0.80%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.87%

APLT -0.45%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 2.04%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.64%

ARDS -12.13%

ARDX 0.91%

ARGX -0.49%

ARNA 0.00%

ARPO -0.90%

ARQT -2.60%

ARTL -2.50%

ARTLW 0.00%

ARVN 8.15%

ARWR -1.64%

ASLN -3.43%

ASMB -4.22%

ASND -1.86%

ATAI -3.70%

ATHA 6.86%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.34%

ATRA -3.60%

ATXI 2.70%

ATXS -0.77%

AUPH -0.90%

AURA 4.55%

AUTL -3.45%

AVBP -3.26%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.35%

AVTX -3.74%

AVXL -5.06%

AXLA 0.00%

AXSM -1.20%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.18%

BCAB -3.27%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.97%

BCTX 10.31%

BCTXW 13.02%

BCYC 0.95%

BDRX -2.54%

BDTX 0.19%

BEAM 2.60%

BFRA -2.91%

BGNE -2.09%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.47%

BLTE -1.03%

BLU 0.03%

BLUE -2.28%

BMEA -13.53%

BMRN 0.53%

BNOX 6.15%

BNTC -1.69%

BNTX -1.64%

BOLD -7.90%

BOLT -0.05%

BPMC -1.47%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -5.19%

BTAI 12.81%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 2.15%

CADL 0.80%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -1.08%

CARA -3.29%

CARM 6.96%

CASI 4.08%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.87%

CCXI 0.00%

CDAK 0.00%

CDIO -3.06%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.79%

CDXS 9.66%

CELC -3.15%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.18%

CGEN -3.31%

CGON -1.43%

CGTX -4.35%

CHMA -6.00%

CHRS 4.11%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.64%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.06%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.61%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -36.09%

CNST 0.00%

CNTA 0.28%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.57%

COYA 1.16%

CPRX -1.75%

CRBP -0.76%

CRBU -7.10%

CRDF 2.21%

CRGX 0.10%

CRIS -1.59%

CRNX -6.14%

CRSP -0.02%

CRTX 2.63%

CRVO -3.20%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.31%

CUE -1.74%

CVAC -7.34%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.55%

CYTO 0.00%

DARE 3.54%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.71%

DNLI -1.83%

DNTH -4.29%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -2.72%

EDSA 4.09%

EFTR 5.35%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -1.24%

ELOX 10.77%

ELTX -5.15%

ELVN -2.14%

ELYM 5.12%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.33%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.96%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.94%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.15%

EXAI -0.19%

EXEL 0.61%

EYEG -0.69%

EYEN 0.59%

EYPT 1.69%

FATE -11.42%

FBIO 0.65%

FBIOP 0.87%

FBLG -7.29%

FBRX -0.02%

FDMT -4.95%

FENC -2.26%

FGEN -9.79%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.37%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.33%

FULC 1.67%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.65%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.01%

GLTO -3.31%

GLUE -3.43%

GLYC -11.78%

GMAB -0.39%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -3.40%

GNTA 3.94%

GOSS -10.88%

GOVX -2.50%

GOVXW 10.89%

GPCR -6.45%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.59%

GRTX -1.66%

GTHX 1.36%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.56%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -0.99%

HOOK 1.55%

HOTH -1.10%

HOWL 1.71%

HRMY 5.05%

HRTX 8.86%

HSTO 0.00%

HUMA 1.52%

HUMAW -6.26%

IBRX -5.43%

ICCC -3.10%

ICPT 0.21%

ICU 14.69%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.16%

IFRX -2.78%

IGMS -0.88%

IKNA -0.30%

IKT -9.93%

IMAB 0.58%

IMCR -3.39%

IMGN 0.02%

IMGO 0.00%

IMMP 4.94%

IMMX -6.90%

IMNM 4.46%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.04%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.22%

INAB -0.71%

INBX -2.65%

INCY -2.23%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 3.22%

INMB 4.97%

INO 2.21%

INSM -1.00%

INTS -1.96%

INVA 0.28%

INZY 2.29%

IOBT -10.94%

IONS 1.60%

IOVA -2.54%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.54%

ISEE 0.38%

ITOS 1.57%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.58%

JANX -4.53%

JAZZ -0.81%

JNCE 0.00%

JSPR -1.60%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -5.47%

KALV -3.55%

KDNY 0.22%

KMPH -0.34%

KNSA -1.85%

KNTE -0.38%

KOD -7.71%

KPRX -4.80%

KPTI -8.93%

KRBP -10.00%

KRON 1.58%

KROS -0.32%

KRRO -2.30%

KRTX 0.03%

KRYS 0.39%

KTRA 11.73%

KTTA -0.65%

KTTAW 0.92%

KURA 0.54%

KYMR -2.87%

KYTX -3.88%

KZIA 4.41%

KZR -0.14%

LABP 0.57%

LBPH -0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.04%

LENZ -2.54%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -10.11%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.78%

LPCN -3.68%

LPTX -2.75%

LQDA 0.41%

LRMR 0.71%

LSTA -1.68%

LTRN 6.48%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.77%

LYEL -34.64%

LYRA 1.47%

MACK 0.10%

MBIO -11.36%

MBRX -1.43%

MCRB 3.08%

MDGL -2.32%

MDNA -13.16%

MDWD 3.56%

MDXG -2.14%

MEIP 0.00%

MESO -1.63%

MGNX -4.78%

MGTA -7.74%

MGTX -1.19%

MGX 2.14%

MIRM 0.51%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX 0.10%

MLYS -6.00%

MNKD -0.67%

MNMD 4.06%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.45%

MORF -3.58%

MREO -1.86%

MRKR -0.43%

MRNA -9.03%

MRNS -5.51%

MRSN -2.86%

MRTX -0.17%

MRUS -0.53%

MRVI -0.29%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.35%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.79%

NKGN 9.91%

NKGNW -18.03%

NKTR 3.27%

NKTX -3.75%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.14%

NMTR -42.97%

NOVN -24.84%

NRBO 16.43%

NRIX -0.53%

NRSN -4.82%

NRSNW 0.00%

NRXP -9.17%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.41%

NTRBW -31.07%

NUVL -0.87%

NVAX -7.57%

NVCT -7.75%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 8.05%

OCS -1.00%

OCUL 1.52%

OCUP 0.65%

ODT -4.27%

OKYO 2.15%

OLMA -4.69%

OMER -2.31%

OMGA 0.63%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.34%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.67%

OVID 0.01%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.87%

PCSA -1.93%

PCVX 0.00%

PDSB -6.65%

PEPG 1.19%

PGEN -6.30%

PHAR 2.19%

PHAS 0.00%

PHAT -0.48%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.92%

PLUR 7.39%

PMN -5.55%

PMVP -2.68%

PNT 0.16%

PPBT -6.84%

PRAX 7.30%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.18%

PRTA -2.74%

PRTC 0.62%

PRTG 1.00%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.71%

PTCT -0.61%

PTE -0.82%

PTGX -0.98%

PTIXW -48.41%

PULM 1.57%

PXMD 4.76%

PYPD 1.71%

PYXS 4.59%

QLGN -2.78%

QNCX 5.70%

QNRX 3.40%

QSI -32.71%

QSIAW -3.13%

QTTB 1.83%

QURE -0.78%

RAIN -1.63%

RANI 4.81%

RAPT -1.30%

RARE 1.66%

RCKT -9.85%

REGN -0.30%

RENB -2.80%

REPL -1.25%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.84%

RGNX -6.49%

RIGL -6.24%

RLAY -4.60%

RLMD 0.00%

RLYB -4.35%

RNA 1.93%

RNAC -4.54%

RNAZ -1.92%

RNXT 1.79%

ROIV -1.62%

ROIVW 4.56%

RPHM -1.40%

RPRX -0.56%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.59%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.70%

RYTM -5.99%

RYZB 0.02%

RZLT 3.49%

SABS -1.37%

SABSW -11.81%

SAGE 0.46%

SANA -2.40%

SAVA -1.48%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.85%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.48%

SGMT -5.08%

SGTX -2.56%

SIOX 22.63%

SLDB -3.10%

SLGL 5.23%

SLN -6.62%

SLNO 0.83%

SLRX 1.21%

SLS -2.56%

SMMT -3.25%

SNDX 3.33%

SNGX -0.38%

SNPX -2.55%

SONN -2.15%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.14%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -6.74%

STRO -1.51%

STSA 0.00%

STTK 7.76%

SURF -0.93%

SVRA -0.39%

SWTX 0.30%

SYBX 1.29%

SYRS -1.72%

TALS -0.73%

TARA -6.67%

TARS -2.01%

TBPH 0.71%

TCBP 9.84%

TCDA 0.00%

TCON 1.37%

TCRR 0.00%

TCRT -1.75%

TCRX 4.92%

TECH -0.86%

TENX -0.32%

TERN -8.23%

TFFP -7.61%

TGTX -7.14%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.40%

TNXP -6.43%

TNYA -4.03%

TPST 5.83%

TRDA -4.67%

TRVI 3.07%

TRVN 0.80%

TSHA -19.03%

TSVT -3.99%

TTNP -6.05%

TVTX 3.14%

TYRA -6.67%

UBX -2.13%

UNCY -4.25%

URGN 2.15%

UTHR -0.06%

VACC 11.36%

VALN -6.70%

VAXX 94.50%

VBIV 0.93%

VBLT -8.77%

VCEL 1.04%

VCNX 9.03%

VCYT -0.75%

VERA -5.55%

VERU 2.62%

VERV -2.29%

VIGL -1.88%

VINC 2.93%

VIR -0.71%

VIRI -5.72%

VIRX 3.98%

VKTX -1.67%

VLON -13.04%

VNDA -3.91%

VOR -6.05%

VRCA 0.28%

VRDN -3.61%

VRNA -1.60%

VRPX 1.02%

VRTX 0.09%

VSTM 4.25%

VTGN -1.51%

VTVT 0.39%

VTYX -2.72%

VXRT -1.93%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -0.60%

WVE -8.39%

XBIO 1.03%

XBIT 6.89%

XCUR 3.77%

XENE -1.89%

XERS 5.23%

XFOR 5.21%

XLO 4.42%

XLRN 0.00%

XNCR 0.47%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.39%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.19%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-11-27	Sr One Capital Management, Llc	Sell	430 578	Common Stock
2023-11-27	Sr One Capital Management, Llc	Sell	178 585	Common Stock
2023-11-15	Worland Stephen T	Buy	5 979	Common Stock
2023-11-15	Byrnes Michael	Buy	4 524	Common Stock
2023-09-09	Loewy Caroline M	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
28.90
Last 94 transactions
Buy: 4 047 347 \| Sell: 1 063 888

Корреляция (AI algo v.1.1b): Undervalued: 0.94% $0.00131 paired level. (Алгоритм отслеживает изменения наиболее коррелирующих акций в режиме реального времени и дает мгновенное обновление)

eFFECTOR Therapeutics, Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

eFFECTOR Therapeutics, Финансовые показатели

Annual	2023
Выручка:	$0
Валовая прибыль:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2023
Выручка:	$0
Валовая прибыль:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2022
Выручка:	$3.55M
Валовая прибыль:	$3.50M (98.51 %)
EPS:	$-7.85

FY	2021
Выручка:	$0.00
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

eFFECTOR Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

eFFECTOR Therapeutics,

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.